TITLE

Biomedical Industrial Sponsorship and Its Impact on the Medical Literature

AUTHOR(S)
Morris, Peter J.
PUB. DATE
August 2006
SOURCE
World Journal of Surgery;Aug2006, Vol. 30 Issue 8, p1371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the issue of the influence of biomedical industrial sponsorship on medical literature. In order to bring a new drug onto the market clinical trials are conducted. These trials take place in clinics in both university and nonuniversity institutions and, for the most part, are sponsored by the pharmaceutical and biomedical industry. There is increasing evidence that the interpretation of data from sponsored studies may be biased.
ACCESSION #
21806120

 

Related Articles

  • Industry sponsorship influence on drug trial results.  // Pharmaceutical Technology Europe;May2007, Vol. 19 Issue 5, p11 

    The article reports on the effect of the pharmaceutical industry sponsorship on drug trial results in U.S. According to the researchers at the University of North Carolina and the Dana Farber Cancer Institute, clinical trials of breast cancer therapies are more likely to have positive results if...

  • Phase III Failures: What Can Be Done? Beltangady, Mohan // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p82 

    Looks at what can be done to prevent failures in Phase III clinical trials. Increasing costs of drug development; Possible reasons for why Phase III trials may fail to confirm what has been learned from Phase II studies; Value of flexible trial designs.

  • Company News.  // Applied Clinical Trials;Apr2006, Vol. 15 Issue 4, p78 

    The article reports on developments concerning the clinical trial and drug development projects of several pharmaceutical and biotechnology companies as of April 2006.

  • CLINICAL TRIALS NEWS.  // Applied Clinical Trials;Apr2006, Vol. 15 Issue 4, p22 

    The article reports on developments relevant to clinical trials and drug development in the U.S. as of April 2006. Key issues discussed include the range of new drugs tested during the clinical trials, the pharmaceutical companies involved in the clinical trial process and the range of ailments...

  • Forcing Pharma's Hand. Varmazis, Catherine // Bio-IT World;Jul/Aug2007, Vol. 6 Issue 6, p38 

    The article focuses on the issues concerning the policies issued by the International Committee of Medical Journal Editors (ICMJE). The policies were issued following criticisms on the hesitance of pharmaceutical companies to register ongoing clinical trials. According to ICMJE, the update on...

  • R&D and Regulatory Update.  // PharmaWatch: CNS;Mar2005, Vol. 4 Issue 3, p15 

    The article offers news briefs related to research and regulatory update. The phase III clinical trial confirms the long-term safety of AstraZeneca's Zonig nasal spray. The shares drug developer Labopharm have increased by nine percent after it received notification of regulatory approval for...

  • In This Issue.  // Nature Reviews Drug Discovery;Dec2005, Vol. 4 Issue 12, p941 

    The article features articles related to the pharmaceutical industry published within the issue, including one that addresses the question whether systems-oriented approaches to drug discovery could bring about a paradigm shift that rescues the industry and another entitled "Teaching Old Drugs...

  • A Swift Predominance of Ex-U.S. Sites. Getz, Kenneth A. // Applied Clinical Trials;Dec2005, Vol. 14 Issue 12, p21 

    The article reports that many pharmaceutical and biotechnology companies in the U.S. are using ex-U.S.-based investigative sites for their clinical trials. Some of the reasons for such trials are that trials overseas are less expensive and physicians there are eager to serve as investigators and...

  • e-Data.  // Pharmaceutical Executive;Jul2007, Vol. 27 Issue 7, p28 

    The article focuses on the increasing demand of electronic data capture (EDC), a technology that acquires analysis drive on clinical trials thru digital advancement for the improvement of pharmaceutical firms in the U.S. It discusses that EDC systems allows, drug companies increased its...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics